SIMILAR PATTERNS OF AMINO ACIDS FOR 5IEF_A_NBVA1005_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nww | LIMONENE-1,2-EPOXIDEHYDROLASE (Rhodococcuserythropolis) |
PF07858(LEH) | 5 | TRP A 130ASP A 132ILE A 116ASP A 101PHE A 75 | NoneHPN A 900 (-4.3A)NoneHPN A 900 (-3.4A)None | 1.28A | 5iefA-1nwwA:undetectable | 5iefA-1nwwA:11.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 9 | ASP A 212ILE A 213ILE A 249TRP A 318ASP A 320MET A 321ASP A 416PHE A 449HIS A 480 | NoneNoneNoneNoneNoneBOG A2000 ( 4.0A)BOG A2000 (-3.0A)NoneNone | 0.48A | 5iefA-2g3nA:38.3 | 5iefA-2g3nA:25.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 9 | ASP A 212ILE A 249TRP A 318ASP A 320MET A 321PHE A 327ASP A 416PHE A 449HIS A 480 | NoneNoneNoneNoneBOG A2000 ( 4.0A)NoneBOG A2000 (-3.0A)NoneNone | 0.65A | 5iefA-2g3nA:38.3 | 5iefA-2g3nA:25.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x2i | ALPHA-1,4-GLUCANLYASE ISOZYME 1 (Gracilariopsislemaneiformis) |
PF01055(Glyco_hydro_31) | 7 | ASP A 412TRP A 551ASP A 553MET A 554ASP A 665PHE A 698HIS A 731 | QPS A1050 (-3.2A)QPS A1050 (-4.8A)QPS A1050 (-3.1A)QPS A1050 (-3.1A)QPS A1050 (-2.7A)QPS A1050 (-4.3A)QPS A1050 (-4.3A) | 0.74A | 5iefA-2x2iA:33.7 | 5iefA-2x2iA:25.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 6 | ASP A 470TRP A 580ASP A 582ASP A 659PHE A 692HIS A 740 | None | 0.34A | 5iefA-2xvgA:42.2 | 5iefA-2xvgA:25.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 6 | TRP A 471ASP A 470TRP A 580ASP A 659PHE A 692HIS A 740 | EDO A1997 ( 4.5A)NoneNoneNoneNoneNone | 0.76A | 5iefA-2xvgA:42.2 | 5iefA-2xvgA:25.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 10 | ASP A 327ILE A 328ILE A 364TRP A 441ASP A 443MET A 444PHE A 450ASP A 542PHE A 575HIS A 600 | 3CU A1001 (-2.7A)3CU A1001 ( 3.9A)3CU A1001 (-4.5A)3CU A1001 (-4.9A)3CU A1001 (-2.7A)3CU A1001 ( 3.9A)None3CU A1001 ( 2.5A)3CU A1001 (-4.5A)3CU A1001 (-3.9A) | 0.47A | 5iefA-3cttA:49.1 | 5iefA-3cttA:29.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 11 | TRP A 327ASP A 355ILE A 356ILE A 392TRP A 470ASP A 472MET A 473PHE A 479ASP A 571PHE A 604HIS A 629 | TRS A6001 ( 3.8A)TRS A6001 (-2.9A)TRS A6001 ( 4.0A)NoneNoneTRS A6001 (-3.2A)TRS A6001 ( 3.7A)NoneTRS A6001 ( 3.7A)TRS A6001 (-4.4A)TRS A6001 (-4.2A) | 0.46A | 5iefA-3lppA:42.7 | 5iefA-3lppA:29.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 9 | TRP A 169ASP A 197ILE A 198ILE A 234MET A 308PHE A 314ASP A 420PHE A 453HIS A 478 | ACR A 664 (-3.7A)ACR A 664 (-2.9A)ACR A 664 (-3.5A)NoneACR A 664 ( 3.8A)ACR A 664 ( 4.2A)ACR A 664 (-2.8A)ACR A 664 (-4.4A)ACR A 664 (-4.2A) | 0.55A | 5iefA-3pocA:35.4 | 5iefA-3pocA:24.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 7 | TRP A 169ASP A 197ILE A 198ILE A 234TRP A 305PHE A 453HIS A 478 | ACR A 664 (-3.7A)ACR A 664 (-2.9A)ACR A 664 (-3.5A)NoneNoneACR A 664 (-4.4A)ACR A 664 (-4.2A) | 0.87A | 5iefA-3pocA:35.4 | 5iefA-3pocA:24.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 10 | ASP A1279ILE A1280ILE A1315TRP A1418ASP A1420MET A1421PHE A1427ASP A1526PHE A1559HIS A1584 | ACR A 1 (-3.2A)ACR A 1 (-4.1A)NoneNoneACR A 1 (-3.6A)ACR A 1 (-3.5A)NoneACR A 1 (-2.8A)ACR A 1 (-4.3A)ACR A 1 (-3.9A) | 0.53A | 5iefA-3topA:38.9 | 5iefA-3topA:27.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 6 | ASP A1279ILE A1280MET A1421ASP A1526PHE A1559HIS A1584 | ACR A 1 (-3.2A)ACR A 1 (-4.1A)ACR A 1 (-3.5A)ACR A 1 (-2.8A)ACR A 1 (-4.3A)ACR A 1 (-3.9A) | 1.46A | 5iefA-3topA:38.9 | 5iefA-3topA:27.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 11 | TRP A 329ASP A 357ILE A 358ILE A 396TRP A 467ASP A 469MET A 470PHE A 476ASP A 568PHE A 601HIS A 626 | ACR A1001 (-4.1A)ACR A1001 (-3.0A)ACR A1001 (-3.6A)ACR A1001 (-4.9A)NoneACR A1001 (-3.2A)ACR A1001 (-3.3A)NoneACR A1001 (-2.7A)ACR A1001 (-4.3A)ACR A1001 (-4.1A) | 0.45A | 5iefA-3welA:41.2 | 5iefA-3welA:29.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 299ILE A 341ASP A 480PHE A 513HIS A 540 | None | 1.41A | 5iefA-4b9yA:38.1 | 5iefA-4b9yA:27.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 7 | ASP A 299ILE A 341TRP A 410ASP A 412ASP A 480PHE A 513HIS A 540 | None | 0.46A | 5iefA-4b9yA:38.1 | 5iefA-4b9yA:27.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 5 | ILE A 341PHE A 377ASP A 480PHE A 513HIS A 540 | None | 1.27A | 5iefA-4b9yA:38.1 | 5iefA-4b9yA:27.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r7u | UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE (Vibrio cholerae) |
PF00275(EPSP_synthase) | 5 | ASP A 397ILE A 396ILE A 393PHE A 239ASP A 405 | None | 1.33A | 5iefA-4r7uA:undetectable | 5iefA-4r7uA:19.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5djw | ALPHA-GLUCOSIDASE II (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 5 | ASP A 211ILE A 212TRP A 319ASP A 321ASP A 401 | None | 1.15A | 5iefA-5djwA:34.8 | 5iefA-5djwA:28.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5djw | ALPHA-GLUCOSIDASE II (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 5 | ASP A 211TRP A 319ASP A 321ASP A 401PHE A 434 | None | 1.38A | 5iefA-5djwA:34.8 | 5iefA-5djwA:28.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 11 | TRP A 415ASP A 443ILE A 444ILE A 480TRP A 554ASP A 556MET A 557PHE A 563ASP A 633PHE A 666HIS A 691 | NoneTRS A1001 (-2.9A)TRS A1001 ( 4.1A)NoneTRS A1001 (-4.9A)TRS A1001 (-3.2A)TRS A1001 (-3.5A)NoneTRS A1001 (-2.8A)TRS A1001 (-4.5A)TRS A1001 (-4.0A) | 0.36A | 5iefA-5dkxA:50.4 | 5iefA-5dkxA:43.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7c | ALPHA-GLUCOSIDASE (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ASP A 348ASP A 460ASP A 523PHE A 556HIS A 588 | None | 0.45A | 5iefA-5f7cA:29.2 | 5iefA-5f7cA:23.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 11 | TRP A 423ASP A 451ILE A 452ILE A 488TRP A 562ASP A 564MET A 565PHE A 571ASP A 640PHE A 673HIS A 698 | 5GF A1021 (-3.1A)5GF A1021 (-2.0A)5GF A1021 (-3.6A)None5GF A1021 (-4.6A)5GF A1021 (-2.1A)5GF A1021 (-2.6A)None5GF A1021 (-2.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 0.31A | 5iefA-5hjrA:61.4 | 5iefA-5hjrA:93.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 7 | TRP A 442ASP A 441TRP A 551ASP A 553ASP A 630PHE A 663HIS A 709 | EDO A1008 (-3.7A)EDO A1008 (-2.8A)NoneEDO A1008 (-2.7A)EDO A1008 (-3.0A)EDO A1008 (-4.3A)EDO A1008 (-4.0A) | 0.83A | 5iefA-5jouA:35.2 | 5iefA-5jouA:25.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 10 | TRP A 376ASP A 404ILE A 441TRP A 516ASP A 518MET A 519PHE A 525ASP A 616PHE A 649HIS A 674 | ACR A1015 ( 4.6A)ACR A1015 (-3.0A)ACR A1015 (-4.3A)NoneACR A1015 (-3.1A)ACR A1015 (-3.3A)NoneACR A1015 (-2.7A)ACR A1015 (-4.3A)ACR A1015 (-4.0A) | 0.58A | 5iefA-5nn8A:50.0 | 5iefA-5nn8A:31.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x7s | GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE (Paenibacillussp. 598K) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF16990(CBM_35)PF17137(DUF5110) | 5 | TRP A 427ASP A 429ASP A 491PHE A 533HIS A 565 | None | 0.52A | 5iefA-5x7sA:8.8 | 5iefA-5x7sA:21.95 |